Zillion Announces the Hiring of Chief Revenue Officer, Jamie Marcellus RN, MBA

3 years ago

Mr. Marcellus brings more than 20 years of experience to the telehealth leader NORWALK, Ct.--(BUSINESS WIRE)--#behavioralhealth--Zillion announces the hiring of…

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

3 years ago

YORBA LINDA, Calif.--(BUSINESS WIRE)--#ERbestpractices--In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was…

Tivic Health Receives Second Global Health & Pharma Award: ClearUP Named 2022 Most Innovative Sinus Relief Solution

3 years ago

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today…

Beltone Introduces Custom Rechargeable Hearing Aids in a Modern Earbud Design

3 years ago

The innovative hearing aids are weatherproof, rechargeable, and custom made allowing for all day comfort, making them ideal for all…

Goodbody Health Granted Care Quality Commission Registration

3 years ago

VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased…

Aerami Therapeutics Appoints Lisa Yañez as Chief Operating Officer

3 years ago

DURHAM, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (the “Company”), a biopharmaceutical company focused on developing inhaled…

Skylight Health Announces Appointment of Interim Chief Financial Officer and Corporate Update

3 years ago

TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state…

INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT

3 years ago

HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the…

Lenire Biosciences Completes License Agreement with University College London for VSN16R, A Novel Clinical Candidate Treatment for Fragile X Syndrome

3 years ago

SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Lenire Biosciences Inc., a biopharmaceutical company developing novel treatments for Fragile X…

GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse

3 years ago

- Intelligent Fingerprinting Limited’s commercial-stage, revenue-generating platform technology would provide an expanded product upon which to leverage the existing GBS…